Parameter | Healthy individuals | Cirrhotic controls | ACLF-ETV treated | ACLF-ETV withdrawal | ACLF-NAs free |
---|---|---|---|---|---|
(n = 30) | (n = 30) | (n = 137) | (n = 47) | (n = 16) | |
Age (years) | 41.13 ± 6.77 | 44.14 ± 10.65 | 46.33 ± 13.65 | 43.70 ± 13.69 | 46.43 ± 13.93 |
Sex (M/F) | 25/5 | 25/5 | 115/23 | 39/8 | 12/4 |
PTA (%) | 85.17 ± 12.32 | 76.15 ± 17.21 | 35.01 ± 15.40 | 32.87 ± 15.17 | 25.14 ± 15.07 |
FIB (g/L) | 2.58 ± 0.61 | 2.14 ± 0.56 | 1.51 ± 0.76 | 1.53 ± 0.76 | 1.66 ± 0.74 |
INR | 1.16 ± 0.16 | 1.16 ± 0.14 | 2.38 ± 1.32 | 2.87 ± 1.33 | 2.95 ± 1.36 |
WBC (109/L) | 5.51 ± 1.23 | 4.25 ± 1.55 | 6.69 ± 2.51 | 6.44 ± 2.26 | 7.08 ± 2.38 |
PLT (109/L) | 201.97 ± 38.25 | 113.29 ± 74.24 | 102.16 ± 64.70 | 83.63 ± 64.79 | 130.47 ± 65.64 |
ALT (U/L) | 21.32 ± 14.23 | 33.81 ± 21.39 | 586.89 ± 744.14 | 431.73 ± 752.23 | 938.76 ± 706.13 |
TBIL (μM) | 11.22 ± 3.74 | 19.26 ± 9.87 | 328.99 ± 129.40 | 360.04 ± 130.81 | 336.34 ± 131.14 |
CHOL (mM) | 3.76 ± 0.57 | 3.41 ± 0.88 | 2.13 ± 1.51 | 1.99 ± 1.51 | 2.23 ± 1.57 |
CREA (μM) | 50.67 ± 10.35 | 53.81 ± 11.43 | 77.88 ± 52.85 | 72.32 ± 53.15 | 77.38 ± 54.65 |
MELD | 24.00 ± 6.23 | 26.00 ± 6.24 | 25.87 ± 6.19 |